Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Hanna Roberts to Animals

This is a "connection" page, showing publications Hanna Roberts has written about Animals.

 
Connection Strength
 
 
 
0.063
 
  1. Chang JY, Monroe DM, Oliver JA, Roberts HR. TFPIbeta, a second product from the mouse tissue factor pathway inhibitor (TFPI) gene. Thromb Haemost. 1999 Jan; 81(1):45-9.
    View in: PubMed
    Score: 0.008
  2. Roberts HR, Monroe DM, Oliver JA, Chang JY, Hoffman M. Newer concepts of blood coagulation. Haemophilia. 1998 Jul; 4(4):331-4.
    View in: PubMed
    Score: 0.008
  3. Chang JY, Monroe DM, Oliver JA, Liles DK, Roberts HR. Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI). Thromb Haemost. 1998 Feb; 79(2):306-9.
    View in: PubMed
    Score: 0.008
  4. Chang JY, Monroe DM, Stafford DW, Brinkhous KM, Roberts HR. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B. J Clin Invest. 1997 Aug 15; 100(4):886-92.
    View in: PubMed
    Score: 0.008
  5. Monroe DM, Hoffman M, Roberts HR, Hedner U. Progressive improvement in wound healing with increased therapy in haemophilia B mice. Haemophilia. 2013 Nov; 19(6):926-32.
    View in: PubMed
    Score: 0.006
  6. Lefkowitz JB, Monroe DM, Kasper CK, Roberts HR. Comparison of the behavior of normal factor IX and the factor IX Bm variant Hilo in the prothrombin time test using tissue factors from bovine, human, and rabbit sources. Am J Hematol. 1993 Jul; 43(3):177-82.
    View in: PubMed
    Score: 0.006
  7. McDonald A, Hoffman M, Hedner U, Roberts HR, Monroe DM. Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost. 2007 Aug; 5(8):1577-83.
    View in: PubMed
    Score: 0.004
  8. McGraw RA, Davis LM, Lundblad RL, Stafford DW, Roberts HR. Structure and function of factor IX: defects in haemophilia B. Clin Haematol. 1985 Jun; 14(2):359-83.
    View in: PubMed
    Score: 0.003
  9. Lusher JM, Eyster ME, Hilgartner MW, Kasper CK, Mannucci PM, Nilsson IM, Penner JA, Roberts HR. Panel discussion on the treatment of patients with factor VIII inhibitors. Prog Clin Biol Res. 1984; 150:323-35.
    View in: PubMed
    Score: 0.003
  10. Wolberg AS, Kon RH, Monroe DM, Ezban M, Roberts HR, Hoffman M. Deencryption of cellular tissue factor is independent of its cytoplasmic domain. Biochem Biophys Res Commun. 2000 Jun 07; 272(2):332-6.
    View in: PubMed
    Score: 0.002
  11. Liles D, Landen CN, Monroe DM, Lindley CM, Read MS, Roberts HR, Brinkhous KM. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B. Thromb Haemost. 1997 May; 77(5):944-8.
    View in: PubMed
    Score: 0.002
  12. Pike IM, Yount WJ, Puritz EM, Roberts HR. Immunochemical characterization of a monoclonal G4,lambda human antibody to factor IX. Blood. 1972 Jul; 40(1):1-10.
    View in: PubMed
    Score: 0.001
  13. Monroe DM, Deerfield DW, Olson DL, Stewart TN, Treanor RE, Roberts HR, Hiskey RG, Pedersen LG. Calcium ion binding to human and bovine factor X. Blood Coagul Fibrinolysis. 1990 Dec; 1(6):633-40.
    View in: PubMed
    Score: 0.001
  14. Turner AD, Monroe DM, Roberts HR, Porter NA, Pizzo SV. p-Amidino esters as irreversible inhibitors of factors IXa and Xa and thrombin. Biochemistry. 1986 Aug 26; 25(17):4929-35.
    View in: PubMed
    Score: 0.001
  15. Pizzo SV, Turner AD, Gonias SL, Monroe DM, Roberts HR, Porter NA. Nontoxic irreversible inhibitors of factors IXa, Xa, and thrombin: potential therapeutic agents for the in vivo regulation of thrombin generation and activity. Ann N Y Acad Sci. 1986; 485:199-203.
    View in: PubMed
    Score: 0.001
  16. Jones ME, Griffith MJ, Monroe DM, Roberts HR, Lentz BR. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa. Biochemistry. 1985 Dec 31; 24(27):8064-9.
    View in: PubMed
    Score: 0.001
  17. Noyes CM, Griffith MJ, Roberts HR, Lundblad RL. Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145. Proc Natl Acad Sci U S A. 1983 Jul; 80(14):4200-2.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)